January 18, 2018 10:00 AM EST
News Briefing

Car­mot clos­es $15M round to ad­vance di­a­betes drug; Ar­gos board clears re­verse stock split, moves to small cap mar­ket

Amber Tong

→ In a last-ditch ef­fort to stay on Nas­daq, Ar­gos Ther­a­peu­tics $ARGS is go­ing for a one-for-twen­ty re­verse stock split, ef­fec­tive af­ter the close …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

De­spite mixed da­ta in Alzheimer's ag­i­ta­tion, Ax­some will still seek FDA ap­proval

Ideaya inks ADC deal with $75M up­front; Amy­lyx, Gubra to de­vel­op long-act­ing GLP-1

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

A service from the Financial Times